title: Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma.
abstract: OBJECTIVE
  It is generally accepted that postoperative chemotherapy does not affect the serum alpha-fetoprotein (AFP) level. The authors report on 3 patients who supposedly showed chemotherapy-related changes in their AFP levels after operation.
  
  
  METHODS
  This study included 3 patients with hepatoblastoma (1 case of PRETEXT III and 2 cases of PRETEXT IV).
  
  
  RESULTS
  One patient with PRETEXT III underwent a complete tumor resection, and the postoperative AFP level decreased until it reached the normal range. However, he consistently exhibited a transient, 2- to 3-fold increase in the AFP after each course of chemotherapy for 3 courses. The chemotherapy regimen had to be stopped because of drug-induced encephalopathy, but he has been followed up for 5 years without any evidence of recurrence, and his AFP level has also remained stable and in the normal range. Two patients with PRETEXT IV, who underwent a curative tumor resection, also showed similar chemotherapy-related changes in AFP levels. Both of these cases were observed only after the administration of routine postoperative chemotherapy instead of administering further high-dose chemotherapy. The AFP level remained stable for 17 months and 7 months after the cessation of chemotherapy in 2 cases, respectively.
  
  
  CONCLUSIONS
  Regarding the postoperative chemotherapy of hepatoblastoma, we have to pay close attention to both the AFP status during chemotherapy as well as the absolute AFP level.
authors.affiliation: Department of Pediatric Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Kubota
authors.forename: Minoru
authors.initials: M
authors.lastname: Yagi
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kanada
authors.forename: Satoru
authors.initials: S
authors.lastname: Yamazaki
authors.forename: Shinji
authors.initials: S
authors.lastname: Tanaka
authors.forename: Keiko
authors.initials: K
authors.lastname: Asami
authors.forename: Atsushi
authors.initials: A
authors.lastname: Ogawa
authors.forename: Akihiro
authors.initials: A
authors.lastname: Watanabe
authors.forename: Haruko
authors.initials: H
authors.lastname: Iwabuchi
authors.forename: Michio
authors.initials: M
authors.lastname: Kaneko
authors.forename: Yukihisa
authors.initials: Y
authors.lastname: Saida
mesh_terms: D002675:Child, Preschool; D003131:Combined Modality Therapy; D018197:Hepatoblastoma / Q000097:blood* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007223:Infant; D008113:Liver Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011182:Postoperative Care; D000509:alpha-Fetoproteins / Q000032:analysis*
chemical_list: D000509:alpha-Fetoproteins